Dr. Toni Rinow is a transformational finance and business leader with over 20 years of experience and a proven track record in international corporate development. Dr. Rinow specializes in guiding companies through inflection points of growth, innovation, technology convergence and business integration. She is a catalyst for growth and expansion and is well known for accelerating revenue streams through acquisitions, corporate development, sales and marketing, and financings. Dr. Rinow transforms data into actionable strategies and most recently served in a NASDAQ traded company raising over $160 million in capital expansion financing and executed on acquisitions securing a Morgan Stanley capital-backed portfolio.

Dr. Rinow led healthcare organizations as General Manager at global nuclear medicine leader Jubilant Draximage Inc and as Chief Operating Officer at Isologic Innovative Radiopharmaceuticals. Her professional career includes leadership roles in both public and private pharmaceutical and healthcare organizations, where she spearheaded acquisitions across Canada, Latin America, Europe, India and USA. Dr. Rinow has successfully facilitated the negotiation of international corporate alliances valued over $100M and overseen an investment portfolio with $400M under management.

Dr. Rinow holds an MBA and a Masters in Accounting from McGill University, as well as a chemical engineering degree from ERASMUS European Higher Institute of Chemistry in Strasbourg, France and a PhD in Biophysics and Chemistry from the University of Montreal. She is also trained in artificial intelligence at MIT Massachusetts Institute of Technology. Dr. Rinow believes in giving back to the community and sat on the Board of Directors in several non-for-profit organizations.